Since Luzp4 was originally described as a CTA we examined Luzp4, Alyref and Uif expression in tumour biopsies from 402 different patients, representing multiple different clinical stages of tumours from a wide range of tissues (Figure 6A, Supplementary Figure S7 and Supplementary Table S2). The gene discussed is FYTTD1; the disease is neoplasm.